Back to search

Article

Partnering with General Practitioners to Optimize Survivorship for Patients with Lymphoma: A phase II Randomized Controlled Trial (The GOSPEL 1 Trial)

2020-08-25

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Survival rates for lymphoma are highest amongst hematological malignancies. In 2019, it was estimated that over 6,400 Australians were diagnosed with lymphoma, a group of hematological malignancies with a high 5-year survival rate of ~76%. There is an increased focus on the promotion of wellness in survivorship and active approaches to reducing morbidity related...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
afbd6579-0666-5486-8234-d84820ee49f6
DOI
10.21203/rs.3.rs-32868/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Partnering with General Practitioners to Optimize Survivorship for Patients with Lymphoma: A phase II Randomized Controlled Trial (The GOSPEL 1 Trial)DOI 10.21203/rs.3.rs-32868/v1
Select a neighboring publication to make it the new centre.